Trial Profile
Dose-escalating, phase 2 safety study of oral lisdexamfetamine in adults with methamphetamine dependence
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Drug dependence; Substance-related disorders
- Focus Adverse reactions; Therapeutic Use
- Acronyms Lisdex
- 20 Jun 2017 Status changed from recruiting to completed.
- 29 Jul 2015 Status changed from not yet recruiting to recruiting, as reported by Australian New Zealand Clinical Trials Registry.
- 12 May 2015 New trial record